Subscribe to RSS
Routine Use of Swallowing Outcome Measures Following Head and Neck Cancer in a Multidisciplinary Clinic Setting
Introduction Chemoradiotherapy treatment for head and neck cancer (HNC) can have a major impact on swallowing function and health-related quality of life.
The use of outcome measures in early detection of patients with swallowing problems provides the opportunity for targeting speech and language therapy (SLT) interventions to aid adaption and promote better clinical outcomes.
Objective The purpose of the present study was to assess relationships between four outcomes measures over time, in a cohort of HNC patients, treated by (chemo-)radiotherapy.
Methods Data were collected at 3 months and 12 months, on 49 consecutive patients with primary squamous cell cancer of the oropharynx, nasopharynx or hypopharynx stage T1–4, N0–2b, M0 disease.
Results Out of 49 eligible patients, 45 completed assessment at 3 months and 20 at 12 months. The 3-month outcomes gave a strong indication of performance at 1 year. There were several strong correlations found between measures. The strongest was between the 3-month Performance Status Scale for Head and Neck Cancer (PSSHN) and the 12-month PSSHN (rs = 0.761, n = 17), the 12-month PSSHN and the 12-month Functional Oral Intake Scale (FOIS) (rs = 0.823, n = 20), and the 12-month University of Washington Head and Neck Quality of Life (UWQoL) swallow and the 12-month Water Swallow Test (WST) capacity (rs = 0.759, n = 17).
Conclusion The UW-QoL swallow item and WST are easy to incorporate into routine care and should be used as part of a standard assessment of swallow outcome. These measures can serve to help screen patients for dysfunction and focus allocation of resources for those who would benefit from more comprehensive assessment and intervention by SLT.
Preliminary data presented as poster at BAHNO 2017.
Received: 21 July 2019
Accepted: 09 January 2020
23 June 2020 (online)
© 2020. Fundação Otorrinolaringologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
- 1 Roe JWG. Swallowing following Intensity Modulated Radiotherapy for Head and Neck Cancer: Functional and Quality of Life Outcomes. 2013. Ph.D., Institute of Cancer Research, University of London;
- 2 Wilson JA, Carding PN, Patterson JM. Dysphagia after nonsurgical head and neck cancer treatment: patients' perspectives. Otolaryngol Head Neck Surg 2011; 145 (05) 767-771
- 3 Kanatas A, Ghazali N, Lowe D, Udberg M, Heseltine J, O'Mahony E, Rogers SN. Issues patients would like to discuss at their review consultation: variation by early and late stage oral, oropharyngeal and laryngeal subsites. Eur Arch Otorhinolaryngol 2013; 270 (03) 1067-1074 DOI: 10.1007/s00405-012-2092-6.
- 4 http://www.handle-on-qol.com . Last accessed May 2019
- 5 Rogers SN, Barber B. Using PROMs to guide patients and practitioners through the head and neck cancer journey. Patient Relat Outcome Meas 2017; 8: 133-142 DOI: 10.2147/PROM.S129012.
- 6 Clarke P, Radford K, Coffey M, Stewart M. Speech and swallow rehabilitation in head and neck cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol 2016; 130 (Suppl. 02) S176-S180
- 7 Thomas L, Jones TM, Tandon S, Katre C, Lowe D, Rogers SN. An evaluation of the University of Washington Quality of Life swallowing domain following oropharyngeal cancer. Eur Arch Otorhinolaryngol 2008; 265 (Suppl. 01) S29-S37
- 8 Pedersen A, Wilson J, McColl E, Carding P, Patterson J. Swallowing outcome measures in head and neck cancer--How do they compare?. Oral Oncol 2016; 52: 104-108
- 9 Chen AY, Frankowski R, Bishop-Leone J, Hebert T, Leyk S, Lewin J, Goepfert H. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001; 127 (07) 870-876
- 10 McHorney CA, Bricker DE, Robbins J, Kramer AE, Rosenbek JC, Chignell KA. The SWAL-QOL outcomes tool for oropharyngeal dysphagia in adults: II. Item reduction and preliminary scaling. Dysphagia 2000; 15 (03) 122-133
- 11 Wallace KL, Middleton S, Cook IJ. Development and validation of a self-report symptom inventory to assess the severity of oral-pharyngeal dysphagia. Gastroenterology 2000; 118 (04) 678-687
- 12 Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrisey M, Engsgtrom MC. Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 2000; 89 (07) 1634-1646
- 13 Nund RL, Brown B, Ward EC, Maclean J, Roe J, Patterson JMartino R. What are we really measuring? A content comparison of swallowing outcome measures for head and neck cancer based on the International Classification of Functioning, Disability and Health (ICF) Dysphagia. https://doi.org/10.1007/s00455-019-10005-0 .E pub 2019 April 3
- 14 Rogers SN, Gwanne S, Lowe D, Humphris G, Yueh B, Weymuller Jr EA. The addition of mood and anxiety domains to the University of Washington quality of life scale. Head Neck 2002; 24 (06) 521-529
- 15 Rogers SN, Lowe D. Screening for dysfunction to promote multidisciplinary intervention by using the University of Washington Quality of Life Questionnaire. Arch Otolaryngol Head Neck Surg 2009; 135 (04) 369-375
- 16 Zuydam AC, Ghazali N, Lowe D, Skelly R, Rogers SN. Evaluation of the limitations of using the University of Washington Quality of Life swallowing domain alone to screen patients in the routine clinical setting. Br J Oral Maxillofac Surg 2013; 51 (07) e148-e154
- 17 Rogers SN, El-Sheikha J, Lowe D. The development of a Patients Concerns Inventory (PCI) to help reveal patients concerns in the head and neck clinic. Oral Oncol 2009; 45 (07) 555-561
- 18 List MA, Ritter-Sterr C, Lansky SB. A performance status scale for head and neck cancer patients. Cancer 1990; 66 (03) 564-569
- 19 Crary MA, Mann GD, Groher ME. Initial psychometric assessment of a functional oral intake scale for dysphagia in stroke patients. Arch Phys Med Rehabil 2005; 86 (08) 1516-1520
- 20 Khan MK, Patterson J, Owen S, Rees S, Gamberini L, Paleri V. North of England Cancer Network Audit group. Comparing the Performance Status Scale and MD Anderson Dysphagia Inventory as swallowing outcome measures in head and neck cancer: a prospective cohort study. Clin Otolaryngol 2015; 40 (04) 321-326
- 21 Kamal M, Barrow MP, Lewin JS, Estrella A, Gunn GB, Shi Q. et al; MD Anderson Head and Neck Cancer Symptom Working Group. Modeling symptom drivers of oral intake in long-term head and neck cancer survivors. Support Care Cancer 2019; 27 (04) 1405-1415
- 22 Roe JW, Carding PN, Drinnan MJ, Harrington KJ, Nutting CM. Swallowing performance and tube feeding status in patients treated with parotid-sparing intensity-modulated radiotherapy for head and neck cancer. Head Neck 2016; 38 (Suppl. 01) E1436-E1444 DOI: 10.1002/hed.24255.
- 23 Rogers SN, Johnson IA, Lowe D. Xerostomia after treatment for oral and oropharyngeal cancer using the University of Washington saliva domain and a Xerostomia-Related Quality-of-Life Scale. Int J Radiat Oncol Biol Phys 2010; 77 (01) 16-23
- 24 Patterson JM, McColl E, Carding PN, Kelly C, Wilson JA. Swallowing performance in patients with head and neck cancer: a simple clinical test. Oral Oncol 2009; 45 (10) 904-907 DOI: 10.1016/j.oraloncology.2009.03.012.
- 25 Patterson JM, Hildreth A, McColl E, Carding PN, Hamilton D, Wilson JA. The clinical application of the 100mL water swallow test in head and neck cancer. Oral Oncol 2011; 47 (03) 180-184
- 26 Hey C, Lange BP, Eberle S, Zaretsky Y, Sader R, Stöver T, Wagenblast J. Water swallow screening test for patients after surgery for head and neck cancer: early identification of dysphagia, aspiration and limitations of oral intake. Anticancer Res 2013; 33 (09) 4017-4021
- 27 Long YB, Wu XP. A randomized controlled trail of combination therapy of neuromuscular electrical stimulation and balloon dilatation in the treatment of radiation-induced dysphagia in nasopharyngeal carcinoma patients. Disabil Rehabil 2013; 35 (06) 450-454 DOI: 10.3109/09638288.2012.697250.
- 28 Tang Y, Shen Q, Wang Y, Lu K, Wang Y, Peng Y. A randomized prospective study of rehabilitation therapy in the treatment of radiation-induced dysphagia and trismus. Strahlenther Onkol 2011; 187 (01) 39-44 DOI: 10.1007/s00066-010-2151-0.
- 29 Zhang L, Huang Z, Wu H, Chen W, Huang Z. Effect of swallowing training on dysphagia and depression in postoperative tongue cancer patients. Eur J Oncol Nurs 2014; 18 (06) 626-629 DOI: 10.1016/j.ejon.2014.06.003.
- 30 O'Hara J, Cosway B, Muirhead C, Leonard N, Goff D, Patterson J. Transoral laser microsurgery±adjuvant therapy versus chemoradiotherapy for stage III and IVA oropharyngeal squamous cell carcinoma: Preliminary comparison of early swallowing outcomes. Head Neck 2015; 37 (10) 1488-1494 DOI: 10.1002/hed.23790.
- 31 O'Hara J, Goff D, Cocks H, Moor J, Hartley C, Muirhead C, Patterson J. One-year swallowing outcomes following transoral laser microsurgery +/- adjuvant therapy versus primary chemoradiotherapy for advanced stage oropharyngeal squamous cell carcinoma. Clin Otolaryngol 2016; 41 (02) 169-175 DOI: 10.1111/coa.12494.
- 32 Owen S, Puvanendran M, Meikle D, Bowe I, O'Hara J, Patterson J, Paleri V. Baseline swallowing measures predict recovery at 6 weeks after transoral robotic surgery for head and neck cancer. Clin Otolaryngol 2017; 42 (02) 366-372 DOI: 10.1111/coa.12731.
- 33 Patterson JM, McColl E, Carding PN, Hildreth AJ, Kelly C, Wilson JA. Swallowing in the first year after chemoradiotherapy for head and neck cancer: clinician- and patient-reported outcomes. Head Neck 2014; 36 (03) 352-358 DOI: 10.1002/hed.23306.
- 34 Patterson JM, McColl E, Carding PN, Wilson JA. Swallowing beyond six years post (chemo)radiotherapy for head and neck cancer; a cohort study. Oral Oncol 2018; 83: 53-58 DOI: 10.1016/j.oraloncology.2018.06.003.
- 35 UICC TNM Classification of malignant Tumours Seventh edition. 2009
- 36 Cohen J. Statistical power analysis for the behavioural sciences. Hillsdale NJ: Lawrence Erlbaum Associates; 1988